The structurally distinct α7 nAChR, composed of five identical α7 subunits, has been investigated for cognitive disorders and schizophrenia [33], but older data suggest that α7 agonists may have antidepressant activity. Here, IGKV2D-24 is linked to Cognitive impairment.